The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Human Liver Model-Global Market Insights and Sales Trends 2024
Synopsis
The global Human Liver Model market size is expected to reach US$ 4002 million by 2029, growing at a CAGR of 10.8% from 2023 to 2029. The market is mainly driven by the significant applications of Human Liver Model in various end use industries. The expanding demands from the Drug Discovery, Education and Others,, are propelling Human Liver Model market. Liver Organoids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liver-on-a-chip segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Human Liver Model market, driven by demand from China, the second largest economy with some signs of stabilising, the Human Liver Model market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Liver Model, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Liver Model market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Liver Model market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Liver Model sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Liver Model covered in this report include Emulate (US), Ascendance Bio (US), HIREL (US), CN Bio (UK), Organovo (US), Cyfuse Biomedical (Japan) and Mimetas, etc.
The global Human Liver Model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Emulate (US)
Ascendance Bio (US)
HIREL (US)
CN Bio (UK)
Organovo (US)
Cyfuse Biomedical (Japan)
Mimetas
Global Human Liver Model market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Liver Model market, Segment by Type:
Liver Organoids
Liver-on-a-chip
2D Models
3D Bioprinting
Others
Global Human Liver Model market, by Application
Drug Discovery
Education
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Liver Model manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Liver Model in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Human Liver Model market size is expected to reach US$ 4002 million by 2029, growing at a CAGR of 10.8% from 2023 to 2029. The market is mainly driven by the significant applications of Human Liver Model in various end use industries. The expanding demands from the Drug Discovery, Education and Others,, are propelling Human Liver Model market. Liver Organoids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Liver-on-a-chip segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Human Liver Model market, driven by demand from China, the second largest economy with some signs of stabilising, the Human Liver Model market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Human Liver Model, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Human Liver Model market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Human Liver Model market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Human Liver Model sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Human Liver Model covered in this report include Emulate (US), Ascendance Bio (US), HIREL (US), CN Bio (UK), Organovo (US), Cyfuse Biomedical (Japan) and Mimetas, etc.
The global Human Liver Model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Emulate (US)
Ascendance Bio (US)
HIREL (US)
CN Bio (UK)
Organovo (US)
Cyfuse Biomedical (Japan)
Mimetas
Global Human Liver Model market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Human Liver Model market, Segment by Type:
Liver Organoids
Liver-on-a-chip
2D Models
3D Bioprinting
Others
Global Human Liver Model market, by Application
Drug Discovery
Education
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Human Liver Model manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Human Liver Model in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Human Liver Model Market Overview
1.1 Human Liver Model Product Overview
1.2 Human Liver Model Market Segment by Type
1.2.1 Liver Organoids
1.2.2 Liver-on-a-chip
1.2.3 2D Models
1.2.4 3D Bioprinting
1.2.5 Others
1.3 Global Human Liver Model Market Size by Type
1.3.1 Global Human Liver Model Market Size Overview by Type (2018-2029)
1.3.2 Global Human Liver Model Historic Market Size Review by Type (2018-2023)
1.3.3 Global Human Liver Model Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Human Liver Model Sales Breakdown by Type (2018-2023)
1.4.2 Europe Human Liver Model Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Human Liver Model Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Human Liver Model Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Human Liver Model Sales Breakdown by Type (2018-2023)
2 Global Human Liver Model Market Competition by Company
2.1 Global Top Players by Human Liver Model Sales (2018-2023)
2.2 Global Top Players by Human Liver Model Revenue (2018-2023)
2.3 Global Top Players by Human Liver Model Price (2018-2023)
2.4 Global Top Manufacturers Human Liver Model Manufacturing Base Distribution, Sales Area, Product Type
2.5 Human Liver Model Market Competitive Situation and Trends
2.5.1 Human Liver Model Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Human Liver Model Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Liver Model as of 2022)
2.7 Date of Key Manufacturers Enter into Human Liver Model Market
2.8 Key Manufacturers Human Liver Model Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Human Liver Model Status and Outlook by Region
3.1 Global Human Liver Model Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Human Liver Model Historic Market Size by Region
3.2.1 Global Human Liver Model Sales in Volume by Region (2018-2023)
3.2.2 Global Human Liver Model Sales in Value by Region (2018-2023)
3.2.3 Global Human Liver Model Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Human Liver Model Forecasted Market Size by Region
3.3.1 Global Human Liver Model Sales in Volume by Region (2024-2029)
3.3.2 Global Human Liver Model Sales in Value by Region (2024-2029)
3.3.3 Global Human Liver Model Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Human Liver Model by Application
4.1 Human Liver Model Market Segment by Application
4.1.1 Drug Discovery
4.1.2 Education
4.1.3 Others
4.2 Global Human Liver Model Market Size by Application
4.2.1 Global Human Liver Model Market Size Overview by Application (2018-2029)
4.2.2 Global Human Liver Model Historic Market Size Review by Application (2018-2023)
4.2.3 Global Human Liver Model Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Human Liver Model Sales Breakdown by Application (2018-2023)
4.3.2 Europe Human Liver Model Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Human Liver Model Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Human Liver Model Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Human Liver Model Sales Breakdown by Application (2018-2023)
5 North America Human Liver Model by Country
5.1 North America Human Liver Model Historic Market Size by Country
5.1.1 North America Human Liver Model Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Human Liver Model Sales in Volume by Country (2018-2023)
5.1.3 North America Human Liver Model Sales in Value by Country (2018-2023)
5.2 North America Human Liver Model Forecasted Market Size by Country
5.2.1 North America Human Liver Model Sales in Volume by Country (2024-2029)
5.2.2 North America Human Liver Model Sales in Value by Country (2024-2029)
6 Europe Human Liver Model by Country
6.1 Europe Human Liver Model Historic Market Size by Country
6.1.1 Europe Human Liver Model Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Human Liver Model Sales in Volume by Country (2018-2023)
6.1.3 Europe Human Liver Model Sales in Value by Country (2018-2023)
6.2 Europe Human Liver Model Forecasted Market Size by Country
6.2.1 Europe Human Liver Model Sales in Volume by Country (2024-2029)
6.2.2 Europe Human Liver Model Sales in Value by Country (2024-2029)
7 Asia-Pacific Human Liver Model by Region
7.1 Asia-Pacific Human Liver Model Historic Market Size by Region
7.1.1 Asia-Pacific Human Liver Model Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Human Liver Model Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Human Liver Model Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Human Liver Model Forecasted Market Size by Region
7.2.1 Asia-Pacific Human Liver Model Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Human Liver Model Sales in Value by Region (2024-2029)
8 Latin America Human Liver Model by Country
8.1 Latin America Human Liver Model Historic Market Size by Country
8.1.1 Latin America Human Liver Model Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Human Liver Model Sales in Volume by Country (2018-2023)
8.1.3 Latin America Human Liver Model Sales in Value by Country (2018-2023)
8.2 Latin America Human Liver Model Forecasted Market Size by Country
8.2.1 Latin America Human Liver Model Sales in Volume by Country (2024-2029)
8.2.2 Latin America Human Liver Model Sales in Value by Country (2024-2029)
9 Middle East and Africa Human Liver Model by Country
9.1 Middle East and Africa Human Liver Model Historic Market Size by Country
9.1.1 Middle East and Africa Human Liver Model Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Human Liver Model Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Human Liver Model Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Human Liver Model Forecasted Market Size by Country
9.2.1 Middle East and Africa Human Liver Model Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Human Liver Model Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Emulate (US)
10.1.1 Emulate (US) Company Information
10.1.2 Emulate (US) Introduction and Business Overview
10.1.3 Emulate (US) Human Liver Model Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Emulate (US) Human Liver Model Products Offered
10.1.5 Emulate (US) Recent Development
10.2 Ascendance Bio (US)
10.2.1 Ascendance Bio (US) Company Information
10.2.2 Ascendance Bio (US) Introduction and Business Overview
10.2.3 Ascendance Bio (US) Human Liver Model Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Ascendance Bio (US) Human Liver Model Products Offered
10.2.5 Ascendance Bio (US) Recent Development
10.3 HIREL (US)
10.3.1 HIREL (US) Company Information
10.3.2 HIREL (US) Introduction and Business Overview
10.3.3 HIREL (US) Human Liver Model Sales, Revenue and Gross Margin (2018-2023)
10.3.4 HIREL (US) Human Liver Model Products Offered
10.3.5 HIREL (US) Recent Development
10.4 CN Bio (UK)
10.4.1 CN Bio (UK) Company Information
10.4.2 CN Bio (UK) Introduction and Business Overview
10.4.3 CN Bio (UK) Human Liver Model Sales, Revenue and Gross Margin (2018-2023)
10.4.4 CN Bio (UK) Human Liver Model Products Offered
10.4.5 CN Bio (UK) Recent Development
10.5 Organovo (US)
10.5.1 Organovo (US) Company Information
10.5.2 Organovo (US) Introduction and Business Overview
10.5.3 Organovo (US) Human Liver Model Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Organovo (US) Human Liver Model Products Offered
10.5.5 Organovo (US) Recent Development
10.6 Cyfuse Biomedical (Japan)
10.6.1 Cyfuse Biomedical (Japan) Company Information
10.6.2 Cyfuse Biomedical (Japan) Introduction and Business Overview
10.6.3 Cyfuse Biomedical (Japan) Human Liver Model Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Cyfuse Biomedical (Japan) Human Liver Model Products Offered
10.6.5 Cyfuse Biomedical (Japan) Recent Development
10.7 Mimetas
10.7.1 Mimetas Company Information
10.7.2 Mimetas Introduction and Business Overview
10.7.3 Mimetas Human Liver Model Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Mimetas Human Liver Model Products Offered
10.7.5 Mimetas Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Human Liver Model Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Human Liver Model Industrial Chain Analysis
11.4 Human Liver Model Market Dynamics
11.4.1 Human Liver Model Industry Trends
11.4.2 Human Liver Model Market Drivers
11.4.3 Human Liver Model Market Challenges
11.4.4 Human Liver Model Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Human Liver Model Distributors
12.3 Human Liver Model Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
